Lunit

Conquering cancer together through the power of AI

Seoul, South Korea · Founded 2013 · $26.0M raised

Headquarters
Seoul
Employees
201–500
Founded
2013
Business Model
B2B
Website
lunit.io
Total Funding
$26.0M
Last Round
$26.0M Series CJan 2020
Rounds
1

About

Lunit is a Seoul-based medical AI company founded in 2013 that develops AI-powered software for cancer screening and precision oncology. Its flagship products — Lunit INSIGHT MMG, CXR, and DBT — are FDA-cleared and CE-marked tools used by over 10,000 medical institutions worldwide to detect breast cancer and lung nodules in imaging studies. Lunit's SCOPE platform provides AI biomarker analysis (PD-L1, HER2, IO) for biopharma R&D and clinical pathology, with partnerships including AstraZeneca, Microsoft, GE Healthcare, and Philips. The company completed its IPO on KOSDAQ in 2022 and acquired Volpara Health in 2024 to expand its breast health AI ecosystem.

Summary

Lunit is an Artificial Intelligence company based in Seoul, South Korea, founded in 2013. It has raised $26.0M in total across 1 round, most recently a $26.0M Series C round in Jan 2020. Investors include Shinhan Investment, InterVest Capital Partners and IMM Investment.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJan 2020
$26.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Lunit on Indexed.vc
<a href="https://indexed.vc/companies/lunit"><img src="https://indexed.vc/api/badge/company/lunit" alt="Lunit on Indexed.vc" width="260" height="76" /></a>